Latest news
Targeted Therapy Resistance in NSCLC: Critical Next Steps - OncodailyOncodaily · Sun, 09 Aug 2026 15:22:32 GMTHER2 Mutations in NSCLC: Critical Risks of Outdated Terms - OncodailyOncodaily · Fri, 07 Aug 2026 16:43:17 GMTLCT Gains Ground in EGFR-Mutated NSCLC - OncLiveOncLive · Fri, 07 Aug 2026 14:05:45 GMTBeyond the Approval: Operationalizing Zongertinib for HER2-Mutant Lung Cancer - Pharmacy TimesPharmacy Times · Wed, 05 Aug 2026 15:22:02 GMTCCL20 Released by Drug–Tolerant Persisters Impairs Immunotherapy in EGFR–Mutant Lung Adenocarcinoma - Wiley Online LibraryWiley Online Library · Mon, 03 Aug 2026 19:17:57 GMT